Counterpoint Mutual Funds’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Sell
26,613
-13,512
-34% -$289K 0.05% 171
2026
Q1
$811K Buy
40,125
+13,605
+51% +$303K 0.12% 87
2025
Q4
$508K Buy
26,520
+5,765
+28% +$121K 0.04% 93
2025
Q3
$500K Sell
20,755
-22,424
-52% -$524K 0.04% 137
2025
Q2
$840K Sell
43,179
-13,730
-24% -$203K 0.07% 61
2025
Q1
$732K Buy
+56,909
New +$915K 0.1% 103
2024
Q4
Sell
-12,327
Closed -$278K 279
2024
Q3
$278K Buy
+12,327
New +$282K 0.05% 149
2023
Q2
Sell
-5,655
Closed -$232K 289
2023
Q1
$232K Buy
5,655
+2,351
+71% +$98.2K 0.2% 9
2022
Q4
$115K Buy
+3,304
New +$116K 0.12% 219
2022
Q2
Sell
-630
Closed -$26K 242
2022
Q1
$26K Buy
+630
New +$27.1K 0.02% 156

Other funds holding ADNT

Counterpoint Mutual Funds's ADNT Position: Q2 2026 in Review

Counterpoint Mutual Funds reduced its Adient (ADNT) stake by 34% in Q2 2026, selling an estimated $289K and leaving 26,613 shares worth $489K. The position accounts for 0.05% of the portfolio, ranked #171.

Counterpoint Mutual Funds first reported a position in ADNT in Q1 2022 and has held it in 10 quarters since. The position peaked at $840K in Q2 2025. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Counterpoint Mutual Funds held 26,613 shares of Adient worth $489K as of Q2 2026.
  • Counterpoint Mutual Funds sold 13,512 Adient shares in Q2 2026, an estimated $289K.
  • Adient made up 0.05% of Counterpoint Mutual Funds's portfolio in Q2 2026, its #171 holding.
  • Counterpoint Mutual Funds first reported a position in Adient in Q1 2022 and has held it in 10 quarters since.
  • Counterpoint Mutual Funds's Adient position peaked at $840K in Q2 2025.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.